Program Design & Consultation
Strong injectable and combination-product programs begin with design rooted in technical truth. Novocol Pharma partners early to evaluate feasibility, guide device and formulation fit, and shape development paths that anticipate real manufacturing, quality, and regulatory demands. Our SMEs and technical PMs help our customers move forward with clarity and confidence.
Strategic Device and Delivery System Guidance for Cartridges and PFS
Device choice affects almost every downstream decision. Novocol Pharma’s role is to help our clients understand these implications early by analyzing how formulations behave within cartridges, pens, and PFS systems. Instead of evaluating components in isolation, we examine how material attributes, mechanical performance, manufacturability, and patient usability converge.
Break-loose and glide-force performance, siliconization, plunger design, needle and stopper selection, machinability, and supplier reliability are considered within the broader context of feasibility and long-term scalability. This integrated perspective supports device decisions that hold up through development, validation, and commercial production.
Project Management Led by Technical Expertise
Our project management at Novocol Pharma functions less like coordination and more like orchestration with high-touch approach for our clients. Each program is led by a technical PM who understands the science, the process, and the operational constraints. This model ensures alignment from the first discussion through scale-up by anticipating questions, challenging assumptions, and maintaining visibility across all workstreams.
Communication rhythms, cross-functional engagement, established risk pathways, and continuity across phases mean progress is tracked, issues are surfaced early, and clients always understand where they stand. Many of our PMs have a long tenure at Novocol Pharma, giving them a level of site and system familiarity that strengthens both strategy and execution.
Program Design and Consultation Capabilities
Feasibility and planning support at Novocol Pharma covers the full spectrum of early-stage development needs that influence downstream success.
Supporting Technologies and Facilities for Stronger Program Foundations
Novocol Pharma’s ability to guide early-stage design is anchored by the infrastructure of a mature sterile manufacturing environment. Our team draws from active development work, analytical depth, and operational insight to shape feasible, scalable plans.
Key assets supporting program design include multiple cartridge and PFS lines, flexible automation-enabled systems, a 200,000 square foot sterile manufacturing campus, and a development organization actively managing more than 15 concurrent CDMO work packages.